1-benzyl-5-methoxy-1H-indole-3-acetamide | 93879-42-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-benzyl-5-methoxy-1H-indole-3-acetamide
• 英文别名: (1-benzyl-5-methoxy-indol-3-yl)-acetic acid amide；(1-Benzyl-5-methoxy-indol-3-yl)-essigsaeure-amid；5-methoxy-1-(phenylmethyl)-1H-indole-3-acetamide；2-(1-benzyl-5-methoxy-2-methyl-indol-3-yl)acetamide；2-(1-benzyl-5-methoxyindol-3-yl)acetamide
• CAS: 93879-42-6
• 化学式: C₁₈H₁₈N₂O₂
• 分子量: 294.353
• InChiKey: YFIDROVIWDFKFW-UHFFFAOYSA-N

物化性质

• 熔点：
  156-158 °C
• 沸点：
  567.0±50.0 °C(Predicted)
• 密度：
  1.19±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  57.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-benzyl-5-methoxy-1H-indole-3-acetamide 在 lithium aluminium tetrahydride 、 sodium 、 三乙胺 作用下， 以 四氢呋喃 、 乙醚 、 二氯甲烷 、 氨 为溶剂， 反应 49.75h， 生成 褪黑素
  参考文献：
  名称：

  Aromatization of 1,6,7,7a-Tetrahydro-2H-indol-2-ones by a Novel Process. Preparation of Key-Intermediate Methyl 1-Benzyl-5-methoxy-1H-indole-3-acetate and the Syntheses of Serotonin, Melatonin, and Bufotenin

  摘要：

  Imine 7 of 1,4-cyclohexanedione mono-ethylene ketal 6 was reacted with maleic anhydride, affording the cyclized adduct 8. Methyl esterification of 8, accompanied by transacetalization, led to the dihydrooxindole derivative 10. Aromatization of 10 was then accomplished with POCl3, leading directly to the key-intermediate title compound 11 in 74% yield from ketone 6. Serotonin, melatonin, and bufotenin were then obtained by standard reactions.

  DOI：

  10.1021/jo0110597
• 作为产物：
  描述：

  5-methoxy-1-(phenylmethyl)-1H-indole-3-acetic acid hydrazide 在 镍 作用下， 以 乙醇 为溶剂， 反应 2.0h， 以89%的产率得到1-benzyl-5-methoxy-1H-indole-3-acetamide
  参考文献：
  名称：

  人非胰腺分泌型磷脂酶A2的吲哚抑制剂。1.吲哚-3-乙酰胺。

  摘要：

  磷脂酶（PLA）在涉及炎症过程的各种类型生物活性脂质的生物合成中产生限速前体。在几种病理条件下已检测到人类非胰腺分泌型磷脂酶A2（hnps-PLA2）水平升高。该酶的抑制剂可以具有治疗用途。进行了广泛的筛选程序以鉴定可能抑制hnps-PLA2的化学结构。通过筛选程序生成的先导化合物之一是5-甲氧基-2-甲基-1-（苯甲基）-1H-吲哚-3-乙酸（13a）。我们描述了一系列吲哚-3-乙酰胺及其衍生化合物的合成，结构-活性关系以及药理活性。

  DOI：

  10.1021/jm960485v

文献信息

• 1H-indole-3-acetamide sPLA.sub.2 inhibitors
  申请人：Eli Lilly and Company

  公开号：US05684034A1

  公开（公告）日：1997-11-04

  A class of novel 1-indole-3-acetamides represented by the formula; ##STR1## is disclosed together with the use of such indole compounds for inhibiting sPLA.sub.2 mediated release of fatty acids.

  一类由以下式表示的新型1-吲哚-3-乙酰胺类化合物被揭示，同时还公开了利用这类吲哚化合物抑制sPLA.sub.2介导的脂肪酸释放的用途。
• 1H-indole-3-acetamide sPLA2 inhibitors
  申请人：Eli Lilly and Company

  公开号：US06252084B1

  公开（公告）日：2001-06-26

  A class of novel 1H-indole-3-acetamides is disclosed together with the use of such indole compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.

  一类新型1H-吲哚-3-乙酰胺被揭示，以及使用这些吲哚化合物抑制sPLA2介导的脂肪酸释放，用于治疗诸如感染性休克等疾病的方法。
• Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 2. Indole-3-acetamides with Additional Functionality
  作者：Robert D. Dillard、Nicholas J. Bach、Susan E. Draheim、Dennis R. Berry、Donald G. Carlson、Nickolay Y. Chirgadze、David K. Clawson、Lawrence W. Hartley、Lea M. Johnson、Noel D. Jones、Emma R. McKinney、Edward D. Mihelich、Jennifer L. Olkowski、Richard W. Schevitz、Amy C. Smith、David W. Snyder、Cynthia D. Sommers、Jean-Pierre Wery

  DOI：10.1021/jm960486n

  日期：1996.1.1

  As reported in our previous paper, a series of indole-3-acetamides which possessed potency and selectivity as inhibitors of human nonpancreatic secretory phospholipase A(2)(hnps-PLA(2)) was developed. The design of these compounds was based on information derived from x-ray crystal structures determined for complexes between the enzyme and its inhibitors. We describe here the further implementation of this structure-based design strategy and continued SAR development to produce indole-3-acetamides with additional functionalities which provide increased interaction with important residues within the enzyme active site. These efforts led to inhibitors with substantially enhanced potency and selectivity.
• The Synthesis of Tryptamines Related to Serotonin
  作者：Elliott Shaw

  DOI：10.1021/ja01621a042

  日期：1955.8
• 1H-indole-3-acetamide derivatives as sPLA2 inhibitors
  申请人：ELI LILLY AND COMPANY

  公开号：EP0620215B1

  公开（公告）日：1999-08-18